Author

Julia Hartmann

German Cancer Research CenterPrimary ORCID profile (0000-0002-5462-7816 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Julia HartmanniD1 paper · Leibniz Institute of Environmental Medicine

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Developmental Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:gene regulatory network inference· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Organism:Drosophila· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Andreas PlückthuniD· 1 shared Asli KayseriliiD· 1 shared Birgit DreieriD· 1 shared Charles S. UmbaughiD· 1 shared Cihan ErkutiD· 1 shared Claudia ScholliD· 1 shared Dan HassoniD· 1 shared Dominic HelmiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andreas PlückthunORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Distinct functions of Nup93 paralogs in tumor growth and Polycomb-mediated repression of JAK/STAT signaling

Michael O’Sullivan, Julia Hartmann, Maya McLellan, Donna J. Thuerauf, Kameneff Bojorquez, Gulay Bengu Ulukaya, Dan Hasson, Prashanth Rangan, Maya Capelson

The paper identifies a tumor-promoting role of Nup93-2 in Drosophila, showing its specific effect on gene silencing and JAK/STAT signaling through Polycomb domains.

bioRxiv · Sep 1, 2026 · PreprintDevelopmental Biology

Selective targeting of TBXT with DARPins identifies regulatory networks and therapeutic vulnerabilities in chordoma

Charles S. Umbaugh, Marie Groth, Cihan Erkut, Kwang-Seok Lee, Joana Marinho, Simon Linder, Florian Iser, Jonas N. Kapp, Petra Schroeter, Simay Dolaner, Asli Kayserili, Dominic Helm, Martin Schneider, Julia Hartmann, Philipp Walch, , Claudia Scholl

This study uses T-DARPins to inhibit TBXT in chordoma cells, revealing its regulome and identifying therapeutic vulnerabilities, including sensitivity to JAK2 inhibitors.

Science Advances · Sep 3, 2025Peer-reviewedCancer Biology